Liquid Pediatric Market Share

  • Report ID: 5504
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Liquid Pediatric Market Share

Asia Pacific Market Forecast

 Asia Pacific industry is set to account for largest revenue share of 39% by 2037, impelled by surge in the importance of pediatric healthcare in the region.. The growing awareness among parents regarding the importance of pediatric healthcare and medication adherence is a significant driver for the market. Parents actively seek child-friendly formulations, such as liquid medications, for their ease of administration and improved palatability, contributing to better medication adherence in children.

 According to a survey by the National Center for Biotechnology Information, 88.9% of liquid medications were used by caregivers who were young and educated women. The survey emphasized the impact of parental awareness on medication choices, highlighting the importance of catering to parental preferences in the market.

North American Market Statistics

The liquid pediatric market in the North American region is projected to hold a remarkable share over the forecast period. The market in the region is growing due to the increasing prevalence of pediatric chronic conditions.

Chronic diseases, such as asthma and diabetes, are rising among children, which require sustained and precise medications. According to the Asthma and Allergy Foundation of America, 4.5 million children in the United States have asthma. This underscores the substantial burden of chronic conditions among the pediatric population in North America, driving the demand for liquid pediatric medications.

Advancements in drug delivery systems specific to pediatric patients contribute significantly to the growth of the liquid pediatric market. Innovations in taste-masking technologies, improved stability of liquid formulations, and user-friendly packaging enhance the overall patient experience. These technological enhancements address the challenges associated with pediatric medication administration, fostering market expansion.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5504
  • Published Date: Jan 03, 2025
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of liquid pediatric is estimated at USD 11.49 billion.

The liquid pediatric market size was valued at USD 10.78 billion in 2024 and is likely to cross USD 28.62 billion by 2037, registering more than 7.8% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of pediatric chronic conditions, rising awareness of pediatric health & medication adherence, and expansion of pediatric clinical research & trials will drive the market growth.

Asia Pacific industry is set to account for largest revenue share of 39% by 2037, impelled by surge in the importance of pediatric healthcare in the region.

The major players in the market are Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Merck & Co., Inc., and others.

Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample